122 related articles for article (PubMed ID: 10547238)
1. Borrelia burgdorferi outer surface protein A vaccine: importance, role, and value.
Sigal LH
J Pediatr; 1999 Nov; 135(5):539-41. PubMed ID: 10547238
[No Abstract] [Full Text] [Related]
2. [Lyme borreliosis--vaccines in the "pipeline"].
Kramer M
MMW Fortschr Med; 1999 Jun; 141(25):52-3. PubMed ID: 10897909
[No Abstract] [Full Text] [Related]
3. The recombinant outer surface protein A (lipOspA) of Borrelia burgdorferi: a Lyme disease vaccine.
Wallich R; Kramer MD; Simon MM
Infection; 1996; 24(5):396-7. PubMed ID: 8923055
[No Abstract] [Full Text] [Related]
4. Availability of Lyme disease vaccine.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1999 Jan; 48(2):35-6, 43. PubMed ID: 9933128
[TBL] [Abstract][Full Text] [Related]
5. Anti-OspA antibody reduces reservoir competence of mice for Borrelia burgdorferi, the agent of Lyme disease.
Brunet LR; Katavolos P; Spielman A; Telford SR
Med Vet Entomol; 1997 Apr; 11(2):198-200. PubMed ID: 9226653
[No Abstract] [Full Text] [Related]
6. Lyme disease vaccine safe for all?
Rahn DW
Postgrad Med; 1999 Jun; 105(7):21. PubMed ID: 10376044
[No Abstract] [Full Text] [Related]
7. Immunization against Lyme disease--an important first step.
Steigbigel RT; Benach JL
N Engl J Med; 1998 Jul; 339(4):263-4. PubMed ID: 9673306
[No Abstract] [Full Text] [Related]
8. Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody.
Pal U; Montgomery RR; Lusitani D; Voet P; Weynants V; Malawista SE; Lobet Y; Fikrig E
J Immunol; 2001 Jun; 166(12):7398-403. PubMed ID: 11390491
[TBL] [Abstract][Full Text] [Related]
9. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group.
Steere AC; Sikand VK; Meurice F; Parenti DL; Fikrig E; Schoen RT; Nowakowski J; Schmid CH; Laukamp S; Buscarino C; Krause DS
N Engl J Med; 1998 Jul; 339(4):209-15. PubMed ID: 9673298
[TBL] [Abstract][Full Text] [Related]
10. Vaccination as a modality to prevent Lyme disease. A status report.
Wormser GP
Infect Dis Clin North Am; 1999 Mar; 13(1):135-48, vii. PubMed ID: 10198796
[TBL] [Abstract][Full Text] [Related]
11. Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis.
Dunne M; al-Ramadi BK; Barthold SW; Flavell RA; Fikrig E
Infect Immun; 1995 Apr; 63(4):1611-4. PubMed ID: 7890431
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against Lyme disease in children.
Feder HM; Beran J; Van Hoecke C; Abraham B; De Clercq N; Buscarino C; Parenti DL
J Pediatr; 1999 Nov; 135(5):575-9. PubMed ID: 10547245
[TBL] [Abstract][Full Text] [Related]
13. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium.
Sigal LH; Zahradnik JM; Lavin P; Patella SJ; Bryant G; Haselby R; Hilton E; Kunkel M; Adler-Klein D; Doherty T; Evans J; Molloy PJ; Seidner AL; Sabetta JR; Simon HJ; Klempner MS; Mays J; Marks D; Malawista SE
N Engl J Med; 1998 Jul; 339(4):216-22. PubMed ID: 9673299
[TBL] [Abstract][Full Text] [Related]
14. From the Food and Drug Administration.
Nightingale SL
JAMA; 1999 Feb; 281(5):408. PubMed ID: 9952188
[No Abstract] [Full Text] [Related]
15. A recombinant vaccine for Lyme disease.
Wallich R; Kramer MD; Simon MM
Behring Inst Mitt; 1994 Dec; (95):106-8. PubMed ID: 7755503
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against lyme disease in healthy children and adolescents: a randomized controlled trial.
Sikand VK; Halsey N; Krause PJ; Sood SK; Geller R; Van Hoecke C; Buscarino C; Parenti D;
Pediatrics; 2001 Jul; 108(1):123-8. PubMed ID: 11433064
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic vaccination against Lyme borreliosis for man and dogs and new strategies to treat established B. burgdorferi infections.
Wallich R; Jahraus O; Simon MM
Int J Med Microbiol; 2002 Jun; 291 Suppl 33():147-9. PubMed ID: 12141739
[No Abstract] [Full Text] [Related]
18. Vaccination against Lyme disease caused by diverse Borrelia burgdorferi.
Fikrig E; Telford SR; Wallich R; Chen M; Lobet Y; Matuschka FR; Kimsey RB; Kantor FS; Barthold SW; Spielman A; Flavell RA
J Exp Med; 1995 Jan; 181(1):215-21. PubMed ID: 7807004
[TBL] [Abstract][Full Text] [Related]
19. Lyme disease vaccine.
Schofield DH; Parenti D
JAMA; 2000 Jan; 283(2):199; author reply 200. PubMed ID: 10634331
[No Abstract] [Full Text] [Related]
20. Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines.
Telford SR; Fikrig E; Barthold SW; Brunet LR; Spielman A; Flavell RA
J Exp Med; 1993 Aug; 178(2):755-8. PubMed ID: 8340764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
